On May 25, 2021 Acacia Pharma Group plc ("Acacia Pharma", the "Group" or the "Company") (EURONEXT: ACPH), a commercial-stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy, reported that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, 1 June 2021 at 08:00 ET (14:00 CEST) (Press release, Acacia Pharma, MAY 25, 2021, View Source [SID1234580527]).

A replay of the presentation will be available on the Jefferies conference website to registered conference attendees for 30 days post the event. Presentation slides will also be made available after the event through the investor section (Financial Reports and Presentations) of the Company’s website, www.acaciapharma.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!